Review
Oct 2026
Novel Nano-delivery Systems for Berberine and Epigallocatechin Gallate: Enhancing Bioavailability and Anti-obesity Therapeutic Efficacy
Obesity affects hundreds of millions of adults worldwide and represents a major risk factor for metabolic disorders, including type 2 diabetes, cardiovascular disease, and non-alcoholic fatty liver disease. Berberine (BBR) and epigallocatechin gallate (EGCG) are bioactive phytochemicals that exhibit anti-obesity ef...
Ashok Thulluru, C. Jangme, Rohini Vichare et al.
· Drug Delivery Letters · 0 citations